Sweetgreen Inc
For the period ended Mar 31, 2024. Filed May 10, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 10, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Condensed Consolidated Financial Statements
SWEETGREEN, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
- DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Sweetgreen, Inc., a Delaware corporation, together with its wholly owned subsidiaries (the “Company”), is a mission-driven, next generation restaurant and lifestyle brand that serves healthy food at scale. The Company’s bold vision is to be as ubiquitous as traditional fast food, but with the transparency and quality that consumers increasingly expect. As of March 31, 2024, the Company owned and operated 227 restaurants in 19 states and Washington, D.C. During the thirteen weeks ended March 31, 2024, the Company had 6 Net New Restaurant Openings.
The Company was founded in November 2006 and incorporated in the state of Delaware in October 2009 and currently is headquartered in Los Angeles, California. The Company’s operations are conducted asone operating segment andone reportable segment, as the Company’s chief operating decision maker, who is the Company’s Chief Executive Officer, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance. The Company’s revenue is derived from retail sales of food and beverages by company-owned restaurants.
The Company has prepared the accompanying unaudited condensed consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial statements and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the Company’s financial position and results of operations. Interim results of operations are not necessarily indicative of the results that may be achieved for the full year. The financial statements and related notes do not include all information and footnotes required by U.S. generally accepted accounting principles for annual reports and should be read in conjunction with the consolidated financial statements for the fiscal year ended December 31, 2023.
Principles of Consolidation—The accompanying condensed consolidated financial statements include the accounts of the Company. All intercompany balances and transactions have been eliminated in consolidation.
Fiscal Year—The Company’s fiscal year is a 52- or 53-week period that ends on the Sunday closest to the last day of December. Fiscal year 2024 is a 52-week period that ends December 29, 2024 and fiscal year 2023 was a 53-week period that ended December 31, 2023. In a 52-week fiscal year, each quarter includes 13 weeks of operations. In a 53-week fiscal year, the first, second and third quarters each include 13 weeks of operations, and the fourth quarter includes 14 weeks of operations.
Management’s Use of Estimates—The condensed consolidated financial statements have been prepared by the Company in accordance with GAAP and the rules and regulations of the SEC. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates made by the Company include the income tax valuation allowance, impairment of long-lived assets and right-of-use assets (“ROU assets”), legal liabilities, valuation of the contingent consideration liability, lease accounting matters, valuation of intangible assets acquired in business combinations, goodwill and stock-based compensation. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from those estimates.
Cash and Cash Equivalents—The Company considers all highly liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. Amounts receivable from credit card processors are converted to cash shortly after the related sales transaction and are considered to be cash equivalents because they are both short-term and highly liquid in nature. Amounts receivable from sales transactions as of March 31, 2024 and December 31, 2023, were $4.5 million and $3.0 million, respectively.
Restricted Cash—The Company’s restricted cash balance relates to certificates of deposit that are collateral for letters of credit to lease agreements entered into by the Company.
The reconciliation of cash and cash equivalents and restricted cash presented in the Company’s accompanying condensed consolidated balance sheets to the total amount shown in its condensed consolidated statements of cash flows is as follows:
| (dollar amounts in thousands) | As of March 31,2024 | As of December 31,2023 |
|---|---|---|
| Reconciliation of cash, cash equivalents and restricted cash: | ||
| Cash and cash equivalents | $243,756 | $257,230 |
| Restricted cash, noncurrent | 125 | 125 |
| Total cash, cash equivalents and restricted cash shown on statement of cash flows | $243,881 | $257,355 |
Recently Issued Accounting Pronouncements Not Yet Adopted—In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The ASU includes amendments requiring enhanced income tax disclosures, primarily related to standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently evaluating the impact of adopting this ASU on its disclosures.
The Company reviewed all other recently issued accounting pronouncements and concluded that they were either not applicable or not expected to have a significant impact to the condensed consolidated financial statements.
- REVENUE RECOGNITION
The following table presents the Company’s revenue for the thirteen weeks ended March 31, 2024 and March 26, 2023 disaggregated by significant revenue channel:
| Thirteen weeks ended | ||
|---|---|---|
| (dollar amounts in thousands) | March 31,2024 | March 26,2023 |
| Owned Digital Channels | $51,812 | $48,261 |
| In-Store Channel (Non-Digital component) | 64,927 | 49,391 |
| Marketplace Channel | 41,111 | 27,410 |
| Total Revenue | $157,850 | $125,062 |
Gift Cards
Gift card liability included in gift card and loyalty liability within the accompanying condensed consolidated balance sheet was as follows:
| (dollar amounts in thousands) | As of March 31,2024 | As of December 31,2023 |
|---|---|---|
| Gift Card Liability | $2,959 | $2,797 |
Revenue recognized from the redemption of gift cards that was included in gift card and loyalty liability at the beginning of the year was as follows:
| Thirteen weeks ended | ||
|---|---|---|
| (dollar amounts in thousands) | March 31,2024 | March 26,2023 |
| Revenue recognized from gift card liability balance at the beginning of the year | $664 | $325 |
- FAIR VALUE
The following tables present information about the Company’s financial liabilities measured at fair value on a recurring basis:
| Fair Value Measurements as of March 31, 2024 | Fair Value Measurements as of December 31, 2023 | |||||||
|---|---|---|---|---|---|---|---|---|
| Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | |
| (dollar amounts in thousands) | ||||||||
| Contingent consideration | 10,377 | — | — | 10,377 | 8,350 | — | — | 8,350 |
The fair value of the contingent consideration was determined based on significant inputs not observable in the market.
In connection with the Company’s acquisition of Spyce on September 7, 2021, the former equity holders of Spyce may receive up to $20 million (in the form of up to 714,285 additional shares of Class A common stock, calculated based on the initial offering price of the Company’s Class A common stock of $28.00 per share sold in the Company’s initial public offering (“IPO”) (the “Reference Price”)), contingent on the achievement of certain performance milestones between the closing date of the acquisition and June 30, 2026.
Additionally, as of the date of the achievement of any of thethree milestones, if the Volume-Weighted Average Price of the Company’s Class A common stock as of such milestone achievement date (“VWAP Price”) is less than the Reference Price, then the Company shall pay to each former equity holder of Spyce, in respect of each share of Class A Common stock issued to such holder upon the achievement of such milestone, an amount in cash equal to the delta between the Reference Price and the VWAP Price. The contingent consideration payable upon the achievement of the three milestones, was valued using the Monte Carlo method. The analysis considered, among other items, the equity value, the contractual terms of the Spyce merger agreement, potential liquidity event scenarios (prior to the IPO), the Company’s credit-adjusted discount rate, equity volatility, risk-free rate, and the probability that milestone targets required for issuance of shares under the contingent consideration will be achieved. During the fourth quarter of fiscal 2023, the first milestone was achieved, which resulted in former equity holders of Spyce being eligible to receive $6.0 million, which was paid during the thirteen weeks ended March 31, 2024. Of this $6.0 million, based on a VWAP Price of $10.20, $2.1 million was issued in the form of Class A common stock, and $3.9 million was paid in cash to the former Spyce equity holders. As the stock was issued and payment was made within one year from December 31, 2023, it was included in other current liabilities within the Consolidated Balance Sheets for the fiscal year ended December 31, 2023 and was issued during the thirteen weeks ended March 31, 2024.
The following table provides a roll forward of the aggregate fair values of the Company’s contingent consideration, for which fair value is determined using Level 3 inputs.
| (dollar amounts in thousands) | Contingent Consideration |
|---|---|
| Balance—December 31, 2023 | $8,350 |
| Change in fair value | 2,027 |
| Balance—March 31, 2024 | $10,377 |
The Company did not record any non-cash impairment charges during the thirteen weeks ended March 31, 2024 and March 26, 2023.
- PROPERTY AND EQUIPMENT
Property and equipment are stated at cost. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life. A summary of property and equipment is as follows:
| (dollar amounts in thousands) | As of March 31,2024 | As of December 31,2023 |
|---|---|---|
| Kitchen equipment | $92,162 | $89,814 |
| Computers and other equipment | 38,806 | 37,984 |
| Furniture and fixtures | 38,308 | 36,692 |
| Leasehold improvements | 271,966 | 262,191 |
| Assets not yet placed in service | 24,969 | 26,269 |
| Total property and equipment | 466,211 | 452,950 |
| Less: accumulated depreciation | (199,079) | (186,048) |
| Property and equipment, net | $267,132 | $266,902 |
Depreciation expense for the thirteen weeks ended March 31, 2024 and March 26, 2023 was $13.7 million and $11.1 million, respectively.
As of March 31, 2024, the Company had 9 facilities under construction due to open during fiscal year 2024. As of December 31, 2023, the Company had 7 facilities under construction, all of which were due to open during fiscal year 2024. Depreciation commences after a store opens and the related assets are placed in service.
Total research and development cost was $0.3 million for both the thirteen weeks ended March 31, 2024 and March 26, 2023. Research and development cost is recorded within general and administrative cost in the Company’s accompanying condensed consolidated statement of operations.
- GOODWILL AND INTANGIBLE ASSETS, NET
During the thirteen weeks ended March 31, 2024, there were no changes in the carrying amount of goodwill of $36.0 million.
The following table presents the Company’s intangible assets, net balances:
| (dollar amounts in thousands) | As of March 31,2024 | As of December 31,2023 |
|---|---|---|
| Internal use software | $40,036 | $38,336 |
| Developed technology | 20,050 | 20,050 |
| Total intangible assets | 60,086 | 58,386 |
| Accumulated amortization | (33,730) | (30,979) |
| Intangible assets, net | $26,356 | $27,407 |
Developed technology intangible assets were recognized in conjunction with the Company’s acquisition of Spyce on September 7, 2021. The estimated useful life of developed technology isfive years and the assets were placed into service during the fiscal year ended December 31, 2023.
Amortization expense for intangible assets was $2.8 million and $2.0 million for the thirteen weeks ended March 31, 2024 and March 26, 2023, respectively.
Estimated future amortization of internal use software and developed technology is as follows:
| (dollar amounts in thousands) | |
|---|---|
| 2024 | $7,483 |
| 2025 | 7,755 |
| 2026 | 5,698 |
| 2027 | 4,083 |
| 2028 | 1,337 |
| Total | $26,356 |
- ACCRUED EXPENSES
Accrued expenses consist of the following:
| (dollar amounts in thousands) | As of March 31,2024 | As of December 31,2023 |
|---|---|---|
| Fixed asset accrual | $3,769 | $3,577 |
| Accrued general and sales tax | 4,475 | 3,438 |
| Rent deferrals | 1,173 | 1,330 |
| Accrued delivery fee | 1,334 | 1,197 |
| Accrued settlements and legal fees | 964 | 1,439 |
| Other accrued expenses | 10,288 | 9,864 |
| Total accrued expenses | $22,003 | $20,845 |
- DEBT
Credit Facility—On December 14, 2020, the Company entered into a First Amended and Restated Revolving Credit, Delayed Draw Term Loan and Security Agreement (as subsequently amended, as discussed below, the “2020 Credit Facility”) with EagleBank. The 2020 Credit Facility superseded the Company’s 2017 revolving credit facility with EagleBank and allows the Company to borrow (i) up to$35.0 million (subsequently increased to $45.0 million) in the aggregate principal amount under the refinanced revolving facility and (ii) up to$10.0 million in the aggregate principal amount under a delayed draw term loan facility, which expired on December 14, 2021, and which was never drawn on. The refinanced revolving facility originally matured on December 14, 2022 (and has since been extended to December 13, 2024). However, if the Company issues certain convertible debt or unsecured indebtedness under the 2020 Credit Facility, then the refinanced revolving facility will mature on the earlier to occur of (i) the maturity date indicated in the previous sentence and (ii)90 days prior to the scheduled maturity date for any portion of such permitted convertible debt or unsecured indebtedness.
On May 9, 2022, the Company and Eagle Bank amended the 2020 Credit Facility to allow for the issuance of Letters of Credit of up to $1.5 million. In connection therewith, the Company entered into a $950,000 irrevocable standby Letter of Credit with Eagle Bank with The Travelers Indemnity Company as the beneficiary in connection with the Company’s workers compensation insurance policy.
On December 13, 2022, the Company and Eagle Bank amended the 2020 Credit Facility to extend the maturity date from December 14, 2022 to December 13, 2024. The amendment also increased the revolving facility cap by $10.0 million, to allow for the Company to borrow up to $45.0 million in the aggregate principal amount under the refinanced revolving facility. The Company incurred $0.1 million of loan origination fees related to the amendment, which was recorded within other current assets on the audited consolidated balance sheets and will be amortized over the life of the facility. Under the 2020 Credit Facility, interest accrues on the outstanding loan balance and is payable monthly at a rate of the adjusted one-month term Secured Overnight Financing Rate, plus 2.90%, with a floor on the interest rate at 3.75%. As of March 31, 2024 and December 31, 2023, the Company hadno outstanding balance under the 2020 Credit Facility.
On April 26, 2023, the Company and Eagle Bank further amended the 2020 Credit Facility to allow for an increase to the issuance of Letters of Credit of up to $3.5 million. In connection therewith, the Company increased its irrevocable standby Letter of Credit with Eagle Bank to $1.95 million, with The Travelers Indemnity Company as the beneficiary in connection with the Company’s workers’ compensation insurance policy. This replaced the previous amendment dated May 9, 2022.
Under the 2020 Credit Facility, the Company is required to maintain certain levels of liquidity (defined as total cash and cash equivalents on hand plus the available amount under the revolving facility) which liquidity amount shall be no less than the trailing 90-day cash burn. The Company was in compliance with the applicable financial covenants as of March 31, 2024 and December 31, 2023.
The obligations under the 2020 Credit Facility are guaranteed by the Company’s existing and future material subsidiaries and secured by substantially all of the Company’s and subsidiaries guarantor’s assets. The 2020 Credit Facility also restricts the Company’s ability, and the ability of the Company’s subsidiary guarantors, to, among other things, incur liens; incur additional indebtedness; transfer or dispose of assets; make acquisitions, change the nature of the business; guarantee obligations; pay dividends to shareholders or repurchase stock; and make advances, loans, or other investments. The 2020 Credit Facility contains customary events of default, including, without limitation, failure to pay the outstanding loans or accrued interest on the due date.
- LEASES
The Company leases restaurants and corporate office space under various non-cancelable lease agreements that expire on various dates through 2038. Lease terms for restaurants generally include a base term of 10 years, with options to extend these leases for additional periods of 5 to 15 years.
The components of lease cost for thethirteen weeks ended March 31, 2024 and March 26, 2023 were as follows:
| Thirteen weeks ended | |||
|---|---|---|---|
| (dollar amounts in thousands) | Classification | March 31,2024 | March 26,2023 |
| Operating lease cost | Occupancy and related expenseGeneral and administrative expensePre-opening costs | $12,382 | $11,829 |
| Variable lease cost | Occupancy and related expenseGeneral and administrative expense | 2,947 | 2,612 |
| Short term lease cost | Occupancy and related expenseGeneral and administrative expense | 114 | 145 |
| Sublease income | General and administrative expense | — | (178) |
| Total lease cost | $15,443 | $14,408 | |
As of March 31, 2024, future minimum lease payments for operating leases consisted of the following:
| (dollar amounts in thousands) | |
|---|---|
| 2024 | $36,157 |
| 2025 | 57,000 |
| 2026 | 55,895 |
| 2027 | 51,660 |
| 2028 | 45,577 |
| Thereafter | 148,323 |
| Total | $394,612 |
| Less: imputed interest | 90,211 |
| Total lease liabilities | $304,401 |
As of March 31, 2024 and December 31, 2023 the Company had additional operating lease commitments of $24.0 million and $25.9 million, respectively, for non-cancelable leases without a possession date, which the Company anticipates will commence in fiscal year 2024 or early 2025. The nature of such lease commitments is consistent with the nature of the leases that the Company has executed thus far.
A summary of lease terms and discount rates for operating leases as of March 31, 2024 and December 31, 2023 is as follows:
| March 31,2024 | December 31,2023 | |
|---|---|---|
| Weighted average remaining lease term (years): | ||
| Operating Leases | 7.29 | 7.41 |
| Weighted average discount rate: | ||
| Operating Leases | 6.59% | 6.51% |
Supplemental cash flow information related to leases for the thirteen weeks ended March 31, 2024 and March 26, 2023:
| March 31,2024 | March 26,2023 | |
|---|---|---|
| Cash paid for amounts included in the measurement of lease liabilities: | ||
| Operating cash flows from operating leases, net of lease incentives | $10,610 | $12,789 |
| Right of use assets obtained in exchange for lease obligations: | ||
| Operating leases | $7,357 | $10,532 |
- COMMON STOCK
As of March 31, 2024 and December 31, 2023, the Company had reserved shares of common stock for issuance in conn ection with the following:
| As of March 31,2024 | As of December 31,2023 | |
|---|---|---|
| Options outstanding under the 2009 Stock Plan, 2019 Equity Incentive Plan, Spyce Food Co. 2016 Stock Option Plan and Grant Plan and 2021 Equity Incentive Plan | 14,569,140 | 13,219,388 |
| Shares reserved for achievement of Spyce milestones | 506,243 | 714,285 |
| Shares reserved for employee stock purchase plan | 4,111,331 | 4,111,331 |
| RSUs and PSUs outstanding under the 2019 Equity Incentive Plan and 2021 Equity Incentive Plan | 7,477,911 | 7,572,945 |
| Shares available for future issuance under the 2021 Equity Incentive Plan | 8,943,292 | 10,572,899 |
| Total reserved shares of common stock | 35,607,917 | 36,190,848 |
- STOCK-BASED COMPENSATION
2021 Equity Incentive Plan
In connection with the Company’s IPO, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”), which allows for issuance of stock options (including incentive stock options and non-qualified stock options), restricted stock units (“RSUs”), including performance-based awards, and other types of awards. The maximum number of shares of common stock that may be issued under the 2021 Plan is 35,166,753, which is the sum of (i)11,500,000 new shares, plus (ii) an additional number of shares consisting of (a) shares that were available for the issuance of awards under any prior equity incentive plans in place (which shall include the Prior Stock Plans (as defined below)) and the options to purchase certain shares of common stock, assumed by the Company, pursuant to the Spyce Food Co. 2016 Stock Option and Grant Plan, prior to the time the Company’s 2021 Plan became effective and (b) any shares of the Company’s common stock subject to outstanding stock options or other stock awards granted under the Prior Stock Plans that on or after the Company’s 2021 Plan became effective, terminate or expire prior to the exercise or settlement; are not issued because the award is settled in cash; are forfeited because of the failure to vest; or are reacquired or withheld (or not issued) to satisfy a tax withholding obligation or the purchase or exercise price. Options granted during, or prior to, the thirteen weeks ended March 31, 2024 generally have vesting terms between twelve months andfour years and have a contractual life of 10 years.
The Company issues shares of Class A common stock upon the vesting and settlement of RSUs and upon the exercises of stock options under the 2021 Plan. The 2021 Plan is administered by the Company’s board of directors (the “Board”), or a duly authorized committee of the Board.
2009 Stock Plan and 2019 Equity Incentive Plan
Prior to the Company’s IPO, the Company granted stock options, RSUs and performance-based restricted stock awards (“PSUs”) to its employees, as well as non-employees (including directors and others who provide substantial services to the Company) under the Company’s 2009 Stock Plan and 2019 Equity Incentive Plan (collectively, the “Prior Stock Plans”). Awards permitted to be granted under the Prior Stock Plans include incentive stock options to the Company’s employees and non-qualified stock options to the
Company’s employees and non-employees, as well as stock appreciation rights, restricted stock awards, RSUs (including PSUs), and other forms of stock awards to the Company’s employees, directors and consultants and any of the Company’s affiliated employees and consultants.
Options granted in the fiscal year ended December 26, 2021 and prior generally have vesting terms betweenone year andfour years and have a contractual life of 10 years. No further stock awards will be granted under the Prior Stock Plans now that the 2021 Equity Incentive Plan is effective; however, awards outstanding under the Prior Stock Plans will continue to be governed by their existing terms.
Spyce Acquisition
In conjunction with the Spyce acquisition, the Company issued shares of Class S stock which converted to the Class A common stock upon the Company’s IPO. Shares of Class S stock that were issued to certain Spyce employees, and the corresponding shares of Class A common stock received by such employees in connection with the Company’s IPO, were subject to time-based service requirements and vested on September 7, 2023, as these requirements were met. As the value is fixed, the grant date fair value of these shares represents the fair value of the shares on the acquisition date. For the thirteen weeks ended March 26, 2023, the Company recognized stock-based compensation expense of $0.8 million related to the vested portion of such shares.
2021 Employee Stock Purchase Plan
In conjunction with the IPO, the Board adopted, and the Company’s stockholders approved, the Company’s 2021 employee stock purchase plan (the “ESPP”). The Company’s ESPP authorizes the issuance of 3,000,000 shares of common stock under purchase rights granted to the Company’s employees or to the employees of any of its designated affiliates. The number of shares of the Company’s common stock reserved for issuance will automatically increase on January 1 of each year for a period of 10 years, which began on January 1, 2023, by the lesser of (i)1% of the total number of shares of the Company’s common stock outstanding on December 31 of the immediately preceding year; and (ii)4,300,000 shares, except before the date of any such increase, the Board may determine that such increase will be less than the amount set forth in clauses (i) and (ii). On January 1, 2023 the ESPP authorized shares increased by 1,111,331 to 4,111,331 in accordance with the above. The Board delegated the authority to manage the ESPP to the Compensation Committee of the Board, which provided that there would be no increase in the share reserve for the ESPP for calendar year 2024.
As of March 31, 2024, there had been no offering period or purchase period under the ESPP, and no such period will begin unless and until determined by the administrator.
Stock Options
The following table summarizes the Company’s stock option activity for the thirteen weeks ended March 31, 2024 and March 26, 2023:
| (dollar amounts in thousands except per share amounts) | Number ofShares | WeightedAverageExercisePrice PerShare | Weighted-AverageRemainingContractual Term(In Years) | AggregateIntrinsicValue |
|---|---|---|---|---|
| Balance—December 31, 2023 | 13,219,388 | $7.77 | 5.97 | $53,758 |
| Options granted | 1,720,782 | 15.52 | ||
| Options exercised | (257,201) | 7.74 | ||
| Options forfeited | (80,989) | 13.51 | ||
| Options expired | (32,840) | 18.97 | ||
| Balance—March 31, 2024 | 14,569,140 | $8.63 | 6.26 | $242,599 |
| Exercisable—March 31, 2024 | 10,419,232 | $6.92 | 5.19 | $191,264 |
| Vested and expected to vest—March 31, 2024 | 14,569,140 | $8.63 | 6.26 | $242,599 |
| (dollar amounts in thousands except per share amounts) | Number ofShares | WeightedAverageExercisePrice PerShare | Weighted-AverageRemainingContractual Term(In Years) | AggregateIntrinsicValue |
|---|---|---|---|---|
| Balance—December 25, 2022 | 13,813,922 | $7.86 | 6.63 | $34,454 |
| Options granted | 1,014,844 | 7.95 | ||
| Options exercised | (160,964) | 4.77 | ||
| Options forfeited | (256,242) | 8.66 | ||
| Options expired | (44,238) | 11.09 | ||
| Balance—March 26, 2023 | 14,367,322 | $7.88 | 6.75 | $17,845 |
| Exercisable—March 26, 2023 | 9,945,317 | $6.24 | 5.79 | $17,638 |
| Vested and expected to vest—March 26, 2023 | 14,367,322 | $7.88 | 6.75 | $17,845 |
The weighted-average fair value of options granted during the thirteen weeks ended March 31, 2024 and March 26, 2023 was$7.58 and$8.43, respectively.
The fair value of each option granted has been estimated as of the date of the grant using the Black-Scholes option-pricing model. The Company has elected to account for forfeitures as they occur.
As of March 31, 2024, there was$23.4 million in unrecognized compensation expense related to unvested stock-based compensation arrangements and is expected to be recognized over a weighted average period 2.22 years.
Restricted Stock Units and Performance Stock Units
Restricted stock units
The following table summarizes the Company’s RSU activity for the thirteen weeks ended March 31, 2024 and March 26, 2023:
| (dollar amounts in thousands except per share amounts) | Number of Shares | Weighted-Average Grant Date Fair Value |
|---|---|---|
| Balance—December 31, 2023 | 951,517 | $17.41 |
| Granted | 369,031 | 16.83 |
| Released | (116,649) | 18.41 |
| Forfeited | (25,988) | 17.47 |
| Balance—March 31, 2024 | 1,177,911 | 17.13 |
| (dollar amounts in thousands except per share amounts) | Number of Shares | Weighted-Average Grant Date Fair Value |
|---|---|---|
| Balance—December 25, 2022 | 1,780,681 | $23.40 |
| Granted | 214,431 | 8.42 |
| Released | (155,558) | 22.15 |
| Forfeited | (229,151) | 22.65 |
| Balance—March 26, 2023 | 1,610,403 | $23.77 |
As of March 31, 2024, unrecognized compensation expense related to RSUs was $12.5 million and is expected to be recognized over a weighted average period of 1.90 years. The fair value of shares released as of the vesting date during thethirteen weeks ended March 31, 2024 was $1.2 million.
Performance stock units
In October 2021, the Company granted 2,100,000 PSUs to each founder (the “founder PSUs”) for a total of 6,300,000 PSUs, under the 2019 Equity Incentive Plan. The founder PSUs vest upon the satisfaction of a service condition and the achievement of certain stock price goals. As of March 31, 2024 unrecognized compensation expense related to the founder PSUs was $22.8 million and is expected to be recognized over a weighted average period of 1.25 years.
Subsequent to the Company’s IPO, the Company issued 321,428 PSUs to the Spyce founders (“Spyce PSUs”) based onthree separate performance-based milestone targets. During the thirteen weeks ended March 31, 2024, the Company modified the number of shares underlying these grants and the vesting terms to remove the performance-based component, resulting in the total number of shares decreasing to 85,395, all of which are scheduled to vest on March 15, 2025. The expense related to these RSUs is included within the RSU section above.
There wereno PSU grants during the thirteen weeks ended March 31, 2024 and March 26, 2023.
A summary of stock-based compensation expense recognized during the thirteen weeks ended March 31, 2024 and March 26, 2023 is as follows:
| Thirteen weeks ended | ||
|---|---|---|
| (dollar amounts in thousands) | March 31,2024 | March 26,2023 |
| Stock-options | $2,336 | $2,472 |
| Restricted stock units | 1,648 | 2,745 |
| Performance stock units | 5,642 | 9,048 |
| Total stock-based compensation | $9,626 | $14,265 |
- INCOME TAXES
The Company’s entire pretax loss for the thirteen weeks ended March 31, 2024 and March 26, 2023 was from its U.S domestic operations. The Company’s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items arising during interim periods. For the thirteen weeks ended March 31, 2024 and March 26, 2023, there were no significant discrete items recorded and the Company recorded $0.1 million and $0.3 million in income tax expense, respectively.
On March 27, 2020, President Trump signed into law the CARES Act (as defined below). Intended to provide economic relief to those impacted by the COVID-19 pandemic, the CARES Act includes provisions, among others, to enhance business’ liquidity and provide for refundable employee retention tax credits, which could be used to offset payroll tax liabilities. On March 11, 2021, President Biden signed the American Rescue Plan Act (“ARPA”). The ARPA includes several provisions, such as measures that extend and expand the employee retention credit, previously enacted under the CARES Act, through September 30, 2021. As there is no authoritative guidance under U.S. GAAP on accounting for government assistance to for-profit business entities, the Company accounts for the ERC (as defined below) by analogy to International Accounting Standard ("IAS”) 20, Accounting for Government Grants and Disclosure of Government Assistance. In accordance with IAS 20, management determined it has reasonable assurance for receipt of the ERC and recorded the ERC benefit of $1.8 million within Labor and other related expenses and $5.1 million within general and administrative expenses in the Condensed Consolidated Statement of Operations for the fiscal year ended December 31, 2023 as an offset to Social Security tax expense. As of March 31, 2024 the Company received $3.4 million cash payment, reducing the ERC receivable within other current assets on the Condensed Consolidated Balance Sheet to $3.6 million.
- NET LOSS PER SHARE
During the thirteen weeks ended March 31, 2024 and March 26, 2023, the rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock were identical, except with respect to voting. As the liquidation and dividend rights were identical, the undistributed earnings were allocated on a proportionate basis and the resulting net loss per share attributable to common stockholders were, therefore, the same for both Class A and Class B common stock on an individual or combined basis.
The following table sets forth the computation of net loss per common share:
| Thirteen weeks ended | ||
|---|---|---|
| March 31,2024 | March 26,2023 | |
| (dollar amounts in thousands) | ||
| Numerator: | ||
| Net loss | $(26,067) | $(33,657) |
| Denominator: | ||
| Weighted-average common shares outstanding—basic and diluted | 112,772,776 | 111,297,064 |
| Earnings per share—basic and diluted | $(0.23) | $(0.30) |
The Company’s potentially dilutive securities, which include preferred stock, time-based vesting restricted stock units, performance stock units, contingently issuable stock and options to purchase common stock, have been excluded from the computation of diluted net loss per share as the effect would be antidilutive. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:
| Thirteen weeks ended | ||
|---|---|---|
| March 31,2024 | March 26,2023 | |
| Options to purchase common stock | 14,569,140 | 14,367,322 |
| Time-based vesting restricted stock units | 1,177,911 | 1,610,403 |
| Performance stock units | 6,300,000 | 6,621,428 |
| Contingently issuable stock | 506,243 | 714,285 |
| Total common stock equivalents | 22,553,294 | 23,313,438 |
- RELATED-PARTY TRANSACTIONS
The Company’s founders and Chief Financial Officer each hold indirect minority passive interests in Luzzatto Opportunity Fund II, LLC, an entity which holds indirect equity interests in Welcome to the Dairy, LLC, which is the owner of the properties leased by the Company for the Company’s principal corporate headquarters. For both the thirteen weeks ended March 31, 2024 and March 26, 2023, total payments to Welcome to the Dairy, LLC, totaled $1.0 million.
- COMMITMENTS AND CONTINGENCIES
Lease Commitments
The Company is obligated under various operating leases related to its office facilities, restaurant locations, and certain equipment under non-cancelable operating leases that expire on various dates. Under certain of these leases, the Company is liable for contingent rent based on a percentage of sales in excess of specified thresholds and typically responsible for its proportionate share of real estate taxes, CAMs and other occupancy costs. Refer to Note 8, Leases, for additional information.
Purchase Obligations
Purchase obligations include agreements to purchase goods or services that are enforceable and legally binding on us and that specify all significant terms. The majority of the Company’s purchase obligations relate to amounts owed for supplies within its restaurants and are due within the next twelve months.
Legal Contingencies
The Company is subject to various claims, lawsuits, governmental investigations and administrative proceedings that arise in the ordinary course of business. The Company does not believe that the ultimate resolution of any of these matters will have a material effect on the Company’s financial position, results of operations, liquidity, or capital resources. However, an increase in the number of these claims, or one or more successful claims under which the Company incurs greater liabilities than the Company currently anticipates, could materially and adversely affect the Company’s business, financial position, results of operations, and cash flows.
- SUBSEQUENT EVENTS
The Company evaluated subsequent events through May 9, 2023, the date its accompanying condensed consolidated financial statements were available to be issued. Except as discussed below, there are no events that require adjustment to or disclosure in these condensed consolidated financial statements.
On April 30, 2024, the Company entered into a sublease agreement with FPM Development, LLC to sublease the former vacated Sweetgreen Support Center (“Phase I”) as well as the current Sweetgreen Support Center (“Phase II”). The term of the sublease commenced on May 1, 2024 and will end on February 28, 2032 (or on such earlier date as the term may sooner expire, as set forth in the Sublease Agreement or the Lease). In accordance with the agreement, substantially all of Phase I was delivered to the Subtenant on May 1, 2024, and the Company anticipates delivering the remainder of Phase I and Phase II on or around August 1, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.